Hwg Holdings LP Edwards Lifesciences Corp Transaction History

Hwg Holdings LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$57.54 - $76.95 $818,851 - $1.1 Million	-14,231 Closed	0 $0
Q4 2019 Jan 09, 2020	BUY	$71.7 - $82.09 $46,174 - $52,865	644 Added 4.74%	14,231 $3.32 Million
Q3 2019 Nov 20, 2019	BUY	$61.55 - $75.43 $242,322 - $296,967	3,937 Added 40.8%	13,587 $2.99 Million
Q2 2019 Jul 29, 2019	SELL	$55.74 - $64.41 $212,815 - $245,917	-3,818 Reduced 28.35%	9,650 $1.78 Million
Q1 2019 Apr 29, 2019	BUY	$47.89 - $64.05 $14,462 - $19,343	302 Added 2.29%	13,468 $2.58 Million
Q4 2018 Feb 19, 2019	SELL	$46.41 - $56.94 $865,685 - $1.06 Million	-18,653 Reduced 58.62%	13,166 $2.02 Million
Q3 2018 Oct 19, 2018	BUY	$45.7 - $58.03 $1.45 Million - $1.85 Million	31,819 New	31,819 $5.54 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

Stay updated on Hwg Holdings LP with notifications on news.